HomeInsightsShare Holding

Glaxosmithkline Pharmaceuticals Ltd Share Holding Pattern

Glaxosmithkline Pharmaceuticals Ltd Share Holding Pattern

stocks purchased

₹ 0.8 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

3.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Promoters Holdings Over Time

Key Highlights

  • FIIs/FPIs increased their stake in the company by 0.54% from March 2024 to June 2024. Mutual funds increased their stake in the company by 0.20% from March 2024 to June 2024.

Latest Shareholding

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20242415.2
21 Nov 20242371.2
19 Nov 20242436.25
18 Nov 20242412.25
14 Nov 20242456.7
13 Nov 20242453.35
12 Nov 20242547
11 Nov 20242537.55
08 Nov 20242555.15
07 Nov 20242610.25

Glaxosmithkline Pharmaceuticals Ltd News Hub

News

GSK Pharma gains as Q2 PAT rises 15% YoY to Rs 249 cr

Profit before exceptional item and tax was at Rs 338.70 crore in the September 2024 quarte...

Read more

30 Oct 202410:39

News

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

29 Oct 202416:10

News

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

25 Oct 202410:38

News

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarte...

Read more

03 Aug 202412:25

News

GlaxoSmithKline Pharmaceuticals to convene board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

18 Jul 202410:38

News

Glaxosmithkline Pharmaceuticals announces change in senior management

Glaxosmithkline Pharmaceuticals announced that Dr. Shalini Menon has been appointed as Exe...

Read more

05 Jul 202413:26

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

May 2024

Transcript

Mar 2023

Transcript

Aug 2021

PPT

Feb 2020

PPT

FAQs for EPS of Glaxosmithkline Pharmaceuticals Ltd

On what factors does the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd change frequently?

The shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Glaxosmithkline Pharmaceuticals Ltd's shareholding pattern updated?

The Glaxosmithkline Pharmaceuticals Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd?

Categories included in the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd important for investors?

The shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd?

The latest shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*